Lexaria Bioscience Corp. (LEXX): Capital Expenditures
$24.6K
Year ended 2025-08-31
$40.8K
Trailing 12 months to 2026-05-31
-20.6%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-08-31 | $24.6K | -42.7% | 2025-11-28, From 2024-09-01 |
| 2024-08-31 | $43.0K | +27.5% | 2025-11-28, From 2023-09-01 |
| 2023-08-31 | $33.7K | -31.4% | 2024-11-26, From 2022-09-01 |
| 2022-08-31 | $49.2K | n/a | 2023-11-20, From 2021-09-01 |
| No annual figure between 2020-08-31 and 2022-08-31. | |||
| 2020-08-31 | $0 | -100.0% | 2020-10-15, From 2019-09-01 |
| 2019-08-31 | $646.2K | n/a | 2020-10-15, From 2018-09-01 |
| No annual figure between 2017-08-31 and 2019-08-31. | |||
| 2017-08-31 | $0 | -100.0% | 2017-11-27, From 2016-09-01 |
| 2016-08-31 | $3.1K | n/a | 2018-11-14, From 2015-09-01 |
| 2015-08-31 | $0 | n/a | 2016-11-29, From 2014-09-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $24.6K | -42.7% |
| Polomar Health Services, Inc. (PMHS) | 2024-12-31 | $90.9K | n/a |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $0 | n/a |
| Hyperion Defi, Inc. (HYPD) | 2024-12-31 | $161.5K | -94.3% |
| Onconetix, Inc. (ONCO) | 2024-12-31 | $28.5K | +762.8% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $22.0K | -67.2% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $442.3K | n/m |
| Rallybio Corp (RLYB) | 2024-12-31 | $0 | -100.0% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | -100.0% |
Compare LEXX, PMHS, BTAIQ, HYPD side by side · Screen every company in Pharmaceutical Preparations ↗